Tarsus Pharmaceuticals Inc (TARS) reports its most successful quarter with $48 million in net sales, expanded coverage, and a ...

Mutual of America Capital Management LLC purchased a new position in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Free Report) in the 3rd quarter, according to the company in its most recent 13F filing ...

The average of price targets set by Wall Street analysts indicates a potential upside of 41.1% in Tarsus Pharmaceuticals (TARS). While the effectiveness of this highly sought-after metric is ...

Tarsus Pharmaceuticals, Inc. (TARS) shares ended the last trading session 10.6% higher at $43.87. The jump came on an impressive volume with a higher-than-average number of shares changing hands ...

On Friday, Tarsus Pharmaceuticals Inc (TARS) stock saw a decline, ending the day at $44.83 which represents a decrease of $-1.82 or -3.90% from the prior close of $46.65. The stock opened at $46.5 and ...

Tarsus Pharmaceuticals, Inc. (TARS) came out with a quarterly loss of $0.61 per share versus the Zacks Consensus Estimate of a loss of $0.90. This compares to loss of $1.28 per share a year ago. These ...

H.C. Wainwright analyst Oren Livnat reiterated a Buy rating on Tarsus Pharmaceuticals (TARS – Research Report) today and set a price ...

Barclays analyst Balaji Prasad assigned a Buy rating to Tarsus Pharmaceuticals (TARS – Research Report) today and set a price target of ...

The Indian Golf Union (IGU) is set to host its first-ever level 3 Tournament Administrators and Referees Seminar (TARS) in April next year, marking a major milestone for the sport in the country. “We ...